Low-dose interleukin-2 in the treatment of metastatic renal-cell carcinoma

Semin Oncol. 1995 Feb;22(1):67-73.
No abstract available

Publication types

  • Research Support, Non-U.S. Gov't
  • Review

MeSH terms

  • Animals
  • Carcinoma, Renal Cell / secondary*
  • Carcinoma, Renal Cell / therapy*
  • Clinical Trials, Phase I as Topic / statistics & numerical data
  • Clinical Trials, Phase II as Topic / statistics & numerical data
  • Combined Modality Therapy
  • Drug Administration Schedule
  • Humans
  • Interferon-alpha / administration & dosage
  • Interleukin-2 / administration & dosage*
  • Interleukin-2 / immunology
  • Kidney Neoplasms / pathology
  • Kidney Neoplasms / therapy*

Substances

  • Interferon-alpha
  • Interleukin-2